CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
186 hedge funds and large institutions have $1.24B invested in Clovis Oncology, Inc. in 2019 Q1 according to their latest regulatory filings, with 40 funds opening new positions, 62 increasing their positions, 49 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
21% more call options, than puts
Call options by funds: $50.7M | Put options by funds: $41.8M
13% more funds holding
Funds holding: 165 → 186 (+21)
Holders
186
Holding in Top 10
5
Calls
$50.7M
Puts
$41.8M
Top Buyers
| 1 | +$34.7M | |
| 2 | +$20M | |
| 3 | +$12.5M | |
| 4 |
CS
Candriam SCA
Strassen, Luxembourg,
Luxembourg
|
+$12.1M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$11.4M |
Top Sellers
| 1 | -$72.9M | |
| 2 | -$32.3M | |
| 3 | -$18.5M | |
| 4 |
SC
Samlyn Capital
New York
|
-$15.7M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$15M |